Shopping Cart
- Remove All
- Your shopping cart is currently empty
HSD17B13-IN-38 (Compound 18.02), an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), is utilized in the study of various liver diseases including hepatitis, liver fibrosis, liver cirrhosis, and hepatocellular carcinoma [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | HSD17B13-IN-38 (Compound 18.02), an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), is utilized in the study of various liver diseases including hepatitis, liver fibrosis, liver cirrhosis, and hepatocellular carcinoma [1]. |
Molecular Weight | 534.5 |
Formula | C21H23F5N6O3S |
Cas No. | 2919797-59-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.